47 research outputs found
Expanding the Applicability of FDM-type Technologies Through Materials Development
Currently, the most common form of additive manufacturing is material extrusion 3D
printing (ME3DP) based on fused deposition modeling (FDM®) technology which relies upon a
thermoplastic monofilament as a base material for the fabrication of three dimensional objects.
The dependence on thermoplastics as a feedstock by ME3DP platforms limits the applicability of
this additive manufacturing method. A clear-cut path towards greater applicability is the
introduction of novel materials with diverse physical properties which maintain compatibility
with 3D printing platforms based on FDM® technology. The work in this paper presents efforts
in the development of polymer matrix composites (PMC)s and polymer blends based on
acrylonitrile butadiene styrene (ABS) and polycarbonate (PC), two thermoplastic materials
commonly used by FDM®-type platforms. Mechanical testing and fractography via scanning
electron microscopy (SEM) were the two main metrics used to characterize these new material
systems. Overcoming barriers to the manufacturing of these novel 3D-printable materials
systems is also presented.Mechanical Engineerin
Studies of Pion Production Near Threshold
This work was supported by National Science Foundation Grant PHY 75-00289 and Indiana Universit
Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume
The concept of age acceleration, the difference between biological age and chronological age, is of growing interest, particularly with respect to age-related disorders, such as Alzheimer’s Disease (AD). Whilst studies have reported associations with AD risk and related phenotypes, there remains a lack of consensus on these associations. Here we aimed to comprehensively investigate the relationship between five recognised measures of age acceleration, based on DNA methylation patterns (DNAm age), and cross-sectional and longitudinal cognition and AD-related neuroimaging phenotypes (volumetric MRI and Amyloid-β PET) in the Australian Imaging, Biomarkers and Lifestyle (AIBL) and the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Significant associations were observed between age acceleration using the Hannum epigenetic clock and cross-sectional hippocampal volume in AIBL and replicated in ADNI. In AIBL, several other findings were observed cross-sectionally, including a significant association between hippocampal volume and the Hannum and Phenoage epigenetic clocks. Further, significant associations were also observed between hippocampal volume and the Zhang and Phenoage epigenetic clocks within Amyloid-β positive individuals. However, these were not validated within the ADNI cohort. No associations between age acceleration and other Alzheimer’s disease-related phenotypes, including measures of cognition or brain Amyloid-β burden, were observed, and there was no association with longitudinal change in any phenotype. This study presents a link between age acceleration, as determined using DNA methylation, and hippocampal volume that was statistically significant across two highly characterised cohorts. The results presented in this study contribute to a growing literature that supports the role of epigenetic modifications in ageing and AD-related phenotypes
New insights into the genetic etiology of Alzheimer's disease and related dementias
Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele